CONTINUUS Pharmaceuticals
Chuntian Hu has a strong background in chemical engineering, with experience in both academia and industry. With a PhD in Chemical Engineering, Chuntian has worked on designing and fabricating microchemical systems to solve various engineering problems. Additionally, as a postdoctoral associate at New York University, Chuntian focused on studying Pd-catalyzed cross-coupling reactions with hydrophilic ligands. During their time at the University of Alabama, Chuntian conducted research on asphaltenes and propane hydrates using spectroscopy techniques. As a Sr Director of Process Development at CONTINUUS Pharmaceuticals, Chuntian continues to apply their expertise in reaction engineering.
This person is not in any offices
CONTINUUS Pharmaceuticals
CONTINUUS’ mission is to produce high-quality drugs that can be delivered to patients more effectively and at a lower cost. CONTINUUS is leveraging a novel continuous manufacturing platform called Integrated Continuous Manufacturing (ICM), initially developed through an $85 M joint research project between Novartis and MIT. With ICM, they will improve affordability and accessibility of pharmaceuticals on a global scale.